TickerFactsScreenerDevelopers

Akari Therapeutics Plc (AKTX) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2010: -$366.0K2011: -$1.01M2012: -$2.13M2013: -$5.45M2014: -$1.48M2015: -$4.97M2016: -$24.62M2017: -$31.60M2018: -$22.77M2019: -$12.92M2020: -$16.95M2021: -$18.85M2022: -$21.50M2023: -$16.43M2024: -$12.55M2025: -$10.57M-$10.57M
2010Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$10.57M+15.8%
2024-$12.55M+23.6%
2023-$16.43M+23.6%
2022-$21.50M-14.1%
2021-$18.85M-11.2%
2020-$16.95M-31.2%
2019-$12.92M+43.3%
2018-$22.77M+27.9%
2017-$31.60M-28.3%
2016-$24.62M-395.9%
2015-$4.97M-236.2%
2014-$1.48M+72.9%
2013-$5.45M-155.4%
2012-$2.13M-111.7%
2011-$1.01M-175.4%
2010-$366.0K—